| Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial AG Sacco, R Chen, FP Worden, DJL Wong, D Adkins, P Swiecicki, ... The Lancet Oncology 22 (6), 883-892, 2021 | 145 | 2021 |
| Use of e-cigarettes and other tobacco products and progression to daily cigarette smoking JP Pierce, R Chen, EC Leas, MM White, S Kealey, MD Stone, ... Pediatrics 147 (2), 2021 | 66 | 2021 |
| Effectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017–2019 R Chen, JP Pierce, EC Leas, T Benmarhnia, DR Strong, MM White, ... Tobacco Control 32 (e2), e145-e152, 2023 | 61 | 2023 |
| Role of e-cigarettes and pharmacotherapy during attempts to quit cigarette smoking: The PATH Study 2013-16 JP Pierce, T Benmarhnia, R Chen, M White, DB Abrams, BK Ambrose, ... PLoS One 15 (9), e0237938, 2020 | 60 | 2020 |
| Use of electronic cigarettes to aid long-term smoking cessation in the United States: prospective evidence from the PATH cohort study R Chen, JP Pierce, EC Leas, MM White, S Kealey, DR Strong, ... American journal of epidemiology 189 (12), 1529-1537, 2020 | 53 | 2020 |
| Incidence of cigarette smoking relapse among individuals who switched to e-cigarettes or other tobacco products JP Pierce, R Chen, S Kealey, EC Leas, MM White, MD Stone, ... JAMA network open 4 (10), e2128810-e2128810, 2021 | 28 | 2021 |
| Effect of graphic warning labels on cigarette packs on US smokers’ cognitions and smoking behavior after 3 months: a randomized clinical trial DR Strong, JP Pierce, K Pulvers, MD Stone, A Villaseñor, M Pu, ... JAMA Network Open 4 (8), e2121387-e2121387, 2021 | 21 | 2021 |
| Daily E-cigarette Use and the Surge in JUUL Sales: 2017–2019 JP Pierce, J Zhang, LE Crotty Alexander, EC Leas, S Kealey, MM White, ... Pediatrics 149 (6), 2022 | 20 | 2022 |
| An open label, nonrandomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell … AG Sacco, R Chen, D Ghosh, DJL Wong, FP Worden, D Adkins, E Pittman, ... Journal of Clinical Oncology 37 (15_suppl), 6033-6033, 2019 | 15 | 2019 |
| Assessing Oximetry Response to Chimeric Antigen Receptor T-cell Therapy against Glioma with 19F MRI in a Murine Model F Chapelin, BI Leach, R Chen, D Lister, K Messer, H Okada, ET Ahrens Radiology: Imaging Cancer 3 (1), e200062, 2021 | 11 | 2021 |
| An open-label, non-randomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients (pts) with recurrent/metastatic (R/M) head and neck … AG Sacco, R Chen, D Ghosh, F Worden, DJ Wong, D Adkins, ... International Journal of Radiation Oncology, Biology, Physics 106 (5), 1121-1122, 2020 | 11 | 2020 |
| Effectiveness and success factors of bilateral arm training after stroke: a systematic review and meta-analysis S Chen, Y Qiu, CC Bassile, A Lee, R Chen, D Xu Frontiers in Aging Neuroscience 14, 875794, 2022 | 8 | 2022 |
| A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma MJ Dennis, AG Sacco, Y Qi, J Bykowski, E Pittman, R Chen, K Messer, ... Oral Oncology 135, 106219, 2022 | 6 | 2022 |
| E-Cigarettes and cessation: the introduction of substantial bias in analyses of PATH Study JP Pierce, EC Leas, T Benmarhnia, SB McMenamin, DR Strong, R Chen, ... Nicotine and Tobacco Research 23 (5), 876-877, 2021 | 6 | 2021 |
| Real-World exposure to graphic warning labels on cigarette packages in US smokers: the CASA randomized trial protocol JP Pierce, DR Strong, MD Stone, A Villaseñor, CV Dimofte, EC Leas, ... Contemporary clinical trials 98, 106152, 2020 | 6 | 2020 |
| An open-label, non-randomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous … AG Sacco, K Messer, A Natsuhara, R Chen, DJL Wong, FP Worden, ... Journal of Clinical Oncology 36 (15_suppl), 6037-6037, 2018 | 6 | 2018 |
| Abstract P3-10-18: Phase 1b trial of cirmtuzumab and paclitaxel for locally advanced, unresectable and metastatic breast cancer RA Shatsky, RB Schwab, TL Helsten, EI Pittman, R Chen, JB Breitmeyer, ... Cancer Research 80 (4_Supplement), P3-10-18-P3-10-18, 2020 | 5 | 2020 |
| Alvimopan for enhanced gastrointestinal recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a randomized controlled trial JM Baumgartner, R Chen, K Messer, J Veerapong, KJ Kelly, ... Journal of the American College of Surgeons 235 (5), 693-701, 2022 | 4 | 2022 |
| Abstract CT134: A phase I study of avelumab, palbociclib, and cetuximab (APC) in recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC) KA Gold, A Sacco, J Bykowski, G Daniels, E Pittman, K Messer, R Chen, ... Cancer Research 81 (13_Supplement), CT134-CT134, 2021 | 3 | 2021 |
| Patient Blood Type Is Associated With Response to Immune Checkpoint Blockade in Metastatic Cancer R Chen, K Hakimi, X Zhang, K Messer, SP Patel The Oncologist 27 (9), e739-e747, 2022 | 1 | 2022 |
Karen MesserProfessor, Family and Preventive Medicine, School of Medicine, University of California San DiegoDirección de correo verificada de ucsd.edu
